ANAB
Anaptysbio Inc
NASDAQ · Biotechnology
$49.73
+1.83 (+3.82%)
Open$48.91
Previous Close$47.90
Day High$51.74
Day Low$48.57
52W High$52.47
52W Low$12.21
Volume—
Avg Volume422.4K
Market Cap1.38B
P/E Ratio—
EPS$-2.82
SectorBiotechnology
Analyst Ratings
Strong Buy
19 analysts
Price Target
+4.1% upside
Current
$49.73
$49.73
Target
$51.79
$51.79
$39.42
$51.79 avg
$66.87
Key Financials
| FY 2026 | FY 2025 | FY 2025 | |
|---|---|---|---|
| Revenue | 89.05M | 78.77M | 175.23M |
| Net Income | -141,681,920 | -112,794,098 | 2.08M |
| Profit Margin | -159.1% | -151.2% | 1.2% |
| EBITDA | -160,399,328 | -134,789,351 | 3.17M |
| Free Cash Flow | — | — | 1.41M |
| Rev Growth | +13.1% | +13.1% | -0.6% |
| Debt/Equity | 4.99 | 4.99 | 0.31 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $223.43 | +2.01% | 165.4 | 394.89B |
| AMGN | Amgen Inc | $384.32 | +4.49% | 26.8 | 206.95B |
| GILD | Gilead Sciences Inc | $152.50 | +2.10% | 23.3 | 189.20B |
| VRTX | Vertex Pharmaceuticals Inc | $477.92 | +4.17% | 33.7 | 123.82B |
| REGN | Regeneron Pharmaceuticals | $785.51 | +2.46% | 18.4 | 83.03B |
| ALNY | Alnylam Pharmaceuticals Inc | $328.16 | -0.93% | 995.2 | 43.35B |